C07D 213/68
Attached in position 4
Official title: attached in position 4
C07D213/68 (Attached in position 4) appears on 520 US grants and 437 published applications in this corpus.
Search patents in C07D- Granted patents
- 520
- Published applications
- 437
- Assignees
- 303
- Inventors
- 1,816
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 5 | 0 |
| 1978 | 9 | 0 |
| 1979 | 8 | 0 |
| 1980 | 5 | 0 |
| 1981 | 12 | 0 |
| 1982 | 5 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 8 | 0 |
| 1989 | 10 | 0 |
| 1990 | 11 | 0 |
| 1991 | 16 | 0 |
| 1992 | 15 | 0 |
| 1993 | 7 | 0 |
| 1994 | 8 | 0 |
| 1995 | 15 | 0 |
| 1996 | 7 | 0 |
| 1997 | 14 | 0 |
| 1998 | 12 | 0 |
| 1999 | 9 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 1 |
| 2002 | 9 | 16 |
| 2003 | 5 | 19 |
| 2004 | 16 | 29 |
| 2005 | 10 | 16 |
| 2006 | 13 | 27 |
| 2007 | 13 | 21 |
| 2008 | 12 | 23 |
| 2009 | 22 | 23 |
| 2010 | 11 | 15 |
| 2011 | 22 | 17 |
| 2012 | 8 | 16 |
| 2013 | 14 | 19 |
| 2014 | 19 | 24 |
| 2015 | 11 | 25 |
| 2016 | 14 | 14 |
| 2017 | 16 | 15 |
| 2018 | 15 | 18 |
| 2019 | 12 | 17 |
| 2020 | 15 | 20 |
| 2021 | 10 | 13 |
| 2022 | 14 | 13 |
| 2023 | 5 | 9 |
| 2024 | 5 | 6 |
| 2025 | 6 | 12 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Chemoselective sensitivity booster for tagging a peptide, peptide conjugate, or similar reactive molecule12 May 2026US 12,625,144 B2Indian Institute of Science Education and Research Bhopal
- Glutamine analogs17 Mar 2026US 12,577,201 B2Jacobio Pharmaceuticals Co., Ltd.
- Pnictogen-containing heterocyclic compounds and their use3 Mar 2026US 12,564,636 B2Colgate University
- Prostaglandin E2 (PGE2) EP4 receptor antagonists20 Jan 2026US 12,527,779 B2Domain Therapeutics
- Amide compounds as activators of the potassium channels kv7.2/kv7.3 useful in the treatment of cns and pns disorders6 Aug 2026US 2026/0226007 A1Angelini Pharma S.P.A.
- Enhancer reagent for a chemiluminescence reaction and compound30 Jul 2026US 2026/0218043 A1FUJIFILM Corporation
- Amide compounds or salts thereof, bactericidal agents for agriculture and horticulture containing said compounds, and method of using same23 Jul 2026US 2026/0206763 A1Nihon Nohyaku Co., Ltd.
- Pyridine derivatives as protein kinase inhibitors16 Jul 2026US 2026/0199300 A1B.C.I. Pharma
- Compounds and compositions as gpr52 modulators18 Jun 2026US 2026/0167615 A1Neurocrine Biosciences, Inc.
Most cited
By later US patents
- Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds232US 6,670,645 B2E. I. Du Pont de Nemours and Company · 2003
- 2-[2-pyridylmethylthio-(sulfinyl)]benzimidazoles166US 4,628,098 ATakeda Chemical Industries, Ltd. · 1986
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007
- 2-(2-pyridylmethylthio (sulfinyl)) benzimidazoles103US 4,689,333 ATakeda Chemical Industries, Ltd. · 1987
- Substituted 2-aminoacetamides and the use thereof101US 6,500,825 B2Euro-Celtique S. A. · 2002